Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/publications/2171-safety-and-pharmacokinetics-of-bivatuzumab-mertansine-in-patients-with-cd44v6-positive-metastatic-breast-cancer-final-results-of-a-phase-i-study/authors
https://forschung.kssg.ch/en/publications/2171-safety-and-pharmacokinetics-of-bivatuzumab-mertansine-in-patients-with-cd44v6-positive-metastatic-breast-cancer-final-results-of-a-phase-i-study/authors